Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?

被引：269

作者：

Viaud, Sophie ^{[2
]}

Thery, Clotilde ^{[3
,4
]}

Ploix, Stephanie

Tursz, Thomas ^{[2
]}

Lapierre, Valerie

Lantz, Olivier ^{[3
,4
]}

Zitvogel, Laurence ^{[2
,5
]}

Chaput, Nathalie ^{[1
,2
]}

机构：

[1] Inst Gustave Roussy, Ctr Invest Clin Biotherapie 507, Lab Therapie Cellulaire, F-94805 Villejuif, France

[2] INSERM, U805, Villejuif, France

[3] Inst Curie, F-75231 Paris, France

[4] INSERM, U932, Paris, France

[5] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France

来源：

CANCER RESEARCH | 2010年 / 70卷 / 04期

关键词：

PEPTIDE-BASED VACCINE; T-CELLS; TRANSFERRIN RECEPTOR; MEMBRANE-VESICLES; NKG2D LIGANDS; DOWN-MODULATE; INDUCE; ACCUMULATION; ACTIVATION; COMPLEXES;

D O I：

10.1158/0008-5472.CAN-09-3276

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Exosomes are nanovesicles originating from late endosomal compartments and secreted by most living cells in ex vivo cell culture conditions. The interest in exosomes was rekindled when B-cell and dendritic cell-derived exosomes were shown to mediate MHC-dependent immune responses. Despite limited understanding of exosome biogenesis and physiological relevance, accumulating evidence points to their bioactivity culminating in clinical applications in cancer. This review focuses on the preclinical studies exploiting the immunogenicity of dendritic cell-derived exosomes (Dex) and will elaborate on the past and future vaccination trials conducted using Dex strategy in melanoma and non-small cell lung cancer patients. Cancer Res; 70(4); 1281-5. (C) 2010 AACR.

引用

页码：1281 / 1285

页数：5

共 43 条

[11] Exosomes from bone marrow dendritic cells pulsed with diphtheria toxoid preferentially induce type 1 antigen-specific IgG responses absence of free antigen [J].

Colino, Jesus ;

Snapper, Clifford M. .

JOURNAL OF IMMUNOLOGY, 2006, 177 (06) :3757-3762

[12] Artificial exosomes as tools for basic and clinical immunology [J].

De la Pena, Hugo ;

Madrigal, J. A. ;

Rusakiewicz, Sylvie ;

Bencsik, Martin ;

Cave, Gareth W. V. ;

Selman, Ali ;

Rees, Robert C. ;

Travers, Paul J. ;

Dodi, Italo A. .

JOURNAL OF IMMUNOLOGICAL METHODS, 2009, 344 (02) :121-132

[13] Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial [J].

Escudier, B ;

Dorval, T ;

Chaput, N ;

André, F ;

Caby, MP ;

Novault, S ;

Flament, C ;

Leboulaire, C ;

Borg, C ;

Amigorena, S ;

Boccaccio, C ;

Bonnerot, C ;

Dhellin, O ;

Movassagh, M ;

Piperno, S ;

Robert, C ;

Serra, V ;

Valente, N ;

Le Pecq, JB ;

Spatz, A ;

Lantz, O ;

Tursz, T ;

Angevin, E ;

Zitvogel, L .

JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)

[14] Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients [J].

Ghiringhelli, Francois ;

Menard, Cedric ;

Puig, Pierre Emmanuel ;

Ladoire, Sylvain ;

Roux, Stephan ;

Martin, Francois ;

Solary, Eric ;

Le Cesne, Axel ;

Zitvogel, Laurence ;

Chauffert, Bruno .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (05) :641-648

[15] Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunity [J].

Hao, Siguo ;

Ye, Zhenmin ;

Yang, Jicheng ;

Bai, On ;

Xiang, Jim .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (02) :146-154

[16] RECEPTOR-MEDIATED ENDOCYTOSIS OF TRANSFERRIN AND RECYCLING OF THE TRANSFERRIN RECEPTOR IN RAT RETICULOCYTES [J].

HARDING, C ;

HEUSER, J ;

STAHL, P .

JOURNAL OF CELL BIOLOGY, 1983, 97 (02) :329-339

[17] Human Placenta Expresses and Secretes NKG2D Ligands via Exosomes that Down-Modulate the Cognate Receptor Expression: Evidence for Immunosuppressive Function [J].

Hedlund, Malin ;

Stenqvist, Ann-Christin ;

Nagaeva, Olga ;

Kjellberg, Lennart ;

Wulff, Marianne ;

Baranov, Vladimir ;

Mincheva-Nilsson, Lucia .

JOURNAL OF IMMUNOLOGY, 2009, 183 (01) :340-351

[18] Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4 [J].

Kim, Seon Hee ;

Bianco, Nicole R. ;

Shufesky, William J. ;

Morelli, Adrian E. ;

Robbins, Paul D. .

JOURNAL OF IMMUNOLOGY, 2007, 179 (04) :2242-2249

[19] Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive [J].

Kim, SH ;

Bianco, N ;

Menon, R ;

Lechman, ER ;

Shufesky, WJ ;

Morelli, AE ;

Robbins, PD .

MOLECULAR THERAPY, 2006, 13 (02) :289-300

[20] Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis [J].

Kim, SH ;

Lechman, ER ;

Bianco, N ;

Menon, R ;

Keravala, A ;

Nash, J ;

Mi, ZB ;

Watkins, SC ;

Gambotto, A ;

Robbins, PD .

JOURNAL OF IMMUNOLOGY, 2005, 174 (10) :6440-6448

← 1 2 3 4 5 →